ESMO and Immunotherapy by Ian Olver
ESMO 2017 Conference Review by Professor Ian Olver AM, for oncologynews.com.au. Almost 24,000 delegates gathered in Madrid…
Browsing: CheckMate trial
AACR 2017: Combination of nivolumab and ipilimumab improved overall survival for advanced melanoma patients
Among patients with advanced melanoma, those who received both nivolumab (Opdivo) and ipilimumab (Yervoy) had…